The mechanism of no-reflow phenomenon, the progress in various therapies of improving microcirculation, and existent problems are reviewed.
现对无复流现象的机制及各种改善心肌微循环治疗的研究进展及存在问题作一综述。In this paper we review no-flow concept, classification and possible mechanisms, diagnosis, and prevention methods.
现对无复流的概念、分类及可能的机制,诊断及防治方法做一综述。Conclusions: Intracoronary administration of tirofiban is effective and safe for ACS patients with no reflow phenomenon after PCI.
结论:冠状动脉内注射国产盐酸替罗非班治疗ACS介入术后无复流患者是有效和安全的。Prevent disease form changing: prevent qi-collateral and blood-collateral, prevent non-reflow after treatment and reoccur after recovery.
既病防变:防止气络及血络、防止治疗后无复流、愈后复发。Results: In group 1, wounds were well healing, no fistula, no perforation, but much food debris nearby.
结果:第1组患儿术后1个月见创口愈合良好,无复裂穿孔,缝线处有呈白色的食物残渣覆盖。Group 3, wounds were well healing, no fistula, no perforation and no food debris.
第3组患儿术后1个月见创口愈合良好,无复裂穿孔,无食物残渣覆盖。Group 2, wounds were well healing, no fistula, no perforation and almost no food debris.
第2组患儿术后1个月见创口愈合良好,无复裂穿孔,食物残渣覆盖较少。Clinical study of the prevention of no-reflow phenomenon during percutaneous coronary intervention
经皮冠状动脉介入术中对无复流现象预防的临床研究Relative factors for angiographic no-reflow phenomenon after primary percutaneous coronary intervention with acute myocardial infarction
急诊经皮冠状动脉介入治疗冠状动脉造影无复流的相关因素